Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Brain Research

• Publication date

  1989-09-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-8993(89)91074-3PMID 2553203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats

  2004cited by this paper
• Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the Cat

  1988cited by this paper
• Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.

  1988cited by this paper
• NMDA receptor activation and early olfactory learning.

  1988cited by this paper
• [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes

  1988cited by this paper
• The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils.

  1988cited by this paper
• Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release.

  1988cited by this paper
• Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain

  1988cited by this paper
• Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.

  1988cited by this paper
• MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

  1988cited by this paper
• Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.

  1988cited by this paper
• Quantitative autoradiography of [3H]‐MK‐801 binding sites in mammalian brain

  1988cited by this paper
• Alterations in local cerebral glucose utilization induced by phencyclidine.

  1987cited by this paper
• CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

  1987cited by this paper
• The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats.

  1987cited by this paper
• Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil

  1987cited by this paper
• Complex synaptic responses of entorhinal cortical cells in the rat to subicular stimulation in vitro: demonstration of an NMDA receptor-mediated component.

  1987cited by this paper
• Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites.

  1987cited by this paper
• Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.

  1987cited by this paper
• Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.

  1987cited by this paper
• PCP‐induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP‐receptor‐acylating agent

  1987cited by this paper
• The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐d‐aspartate receptor in rat brain

  1987cited by this paper
• Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.

  1987cited by this paper
• Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.

  1987cited by this paper
• Non-competitive antagonists of excitatory amino acid receptors

  1987cited by this paper
• Excitatory amino acids in the brain - focus on NMDA receptors

  1987cited by this paper
• NMDA receptors - their role in long-term potentiation

  1987cited by this paper
• The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

  1986cited by this paper
• Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

  1986cited by this paper
• Neurophysiology of limbic system pathways in the rat: projections from the subicular complex and hippocampus to the entorhinal cortex.

  1986cited by this paper
• A magnesium‐sensitive post‐synaptic potential in rat cerebral cortex resembles neuronal responses to N‐methylaspartate.

  1986cited by this paper
• Effects of sigma agonist compounds on local cerebral glucose utilization: relationship to psychotomimetic properties.

  1986cited by this paper
• CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.

  1986cited by this paper
• Glutamic Acid as a Putative Transmitter of the Interhemispheric Corticocortical Connections in the Rat

  1986cited by this paper
• Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain

  1985cited by this paper
• Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.

  1985cited by this paper
• Intrinsic projections of the retrohippocampal region in the rat brain. I. The subicular complex

  1985cited by this paper
• Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.

  1985cited by this paper
• Dual‐component amino‐acid‐mediated synaptic potentials: excitatory drive for swimming in Xenopus embryos.

  1985cited by this paper
• Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

  1984cited by this paper
• Effects of acute administration of caffeine on local cerebral glucose utilization in the rat.

  1984cited by this paper
• Glucose utilization in the Papez circuit: effects of oxotremorine and scopolamine.

  1984cited by this paper
• Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.

  1984cited by this paper
• Comparative Effects of Acute and Chronic Administration of Amphetamine on Local Cerebral Glucose Utilization in the Conscious Rat

  1983cited by this paper
• The Effects of Apomorphine upon Local Cerebral Glucose Utilization in Conscious Rats and in Rats Anesthetized with Chloral Hydrate

  1983cited by this paper
• Altered metabolic activity in the cerebral cortex of rats exposed to ketamine

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Local cerebral glucose consumption in the rat. I. Effects of halothane anesthesia

  1983cited by this paper
• Effects of excitatory amino acids and their antagonists on membrane and action potentials of cat caudate neurones.

  1983cited by this paper
• The Influence of Droperidol, Diazepam, and Physostigmine on Ketamine‐induced Behavior and Brain Regional Glucose Utilization in Rat

  1982cited by this paper
• Mapping Functional Alterations in the CNS With [14C]Deoxyglucose

  1982cited by this paper
• A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice

  1982cited by this paper
• Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  1982cited by this paper
• Local changes in cerebral glucose utilization during ketamine anesthesia.

  1982cited by this paper
• Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  1982cited by this paper
• Local Changes in Cerebral Glucose Utilization during Ketamine Anesthesia

  1982cited by this paper
• Effects of the Putative GABAergic Agonists, Muscimol and THIP, upon Local Cerebral Glucose Utilisation

  1982cited by this paper
• The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.

  1982cited by this paper
• [3H]2-Deoxy-D-glucose capture in the hippocampus and dentate gyrus of ketamine-anesthetized rat.

  1981cited by this paper
• Release of endogenous amino acid neurotransmitter candidates from rat olfactory cortex slices: possible regulatory mechanisms and the effects of pentobarbitone.

  1980cited by this paper
• Laminar organization of thalamic projections to the rat neocortex.

  1980cited by this paper
• Basis of phencyclidine's ability to decrease the synaptosomal accumulation of 3H-catecholamines.

  1980cited by this paper
• Localisation of phencyclidine-induced changes in brain energy metabolism

  1979cited by this paper
• EFFECTS OF d‐ AND l‐AMPHETAMINE ON LOCAL CEREBRAL GLUCOSE UTILIZATION IN THE CONSCIOUS RAT 1

  1979cited by this paper
• AMINO ACIDS AS NEUROTRANSMITTERS OF CORTICOFUGAL NEURONES IN THE RAT: A COMPARISON OF GLUTAMATE AND ASPARTATE

  1979cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• Glutamate as transmitter of hippocampal perforant path

  1977cited by this paper
• Convergent thalamic and mesencephalic projections to the anterior medial cortex in the rat

  1976cited by this paper
• Specific release of endogenous glutamate from piriform cortex stimulated in vitro.

  1976cited by this paper
• Unitary analysis of opossum prepyriform cortex.

  1973cited by this paper
• Projections from the cingulate cortex in the rat.

  1969cited by this paper
• Electrical activity observed in guinea‐pig olfactory cortex maintained in vitro

  1968cited by this paper
• A PROPOSED MECHANISM OF EMOTION

  1937cited by this paper

• Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids

  2019cites this paper
• Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression

  2018cites this paper
• Comparison of Glutamate Turnover in Nerve Terminals and Brain Tissue During [1,6-13C2]Glucose Metabolism in Anesthetized Rats

  2016cites this paper
• Investigation of Mechanisms for MK-801-Induced Neurotoxicity Utilizing Metabolomic Approach.

  2015cites this paper
• [18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity.

  2013cites this paper
• Neural circuit analysis of the dorsal nucleus of the lateral lemniscus and new viral approaches to neural circuit analysis in Mongolian gerbils

  2012cites this paper
• experimental stroke in rats noncompetitive N-methyl-D-aspartate antagonist and reperfusion in Diffusion and perfusion magnetic resonance imaging studies to evaluate a

  2011cites this paper
• Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

  2008cites this paper
• A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat.

  2008cites this paper
• Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol

  2007influential citation
• Investigation of the Functional Effects of Two Novel Ampakines in the CNS

  2007cites this paper
• Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis.

  2007cites this paper
• Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats

  2005cites this paper
• Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.

  2005cites this paper
• The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801

  2004cites this paper
• The AMPA Receptor Potentiator LY404187 Increases Cerebral Glucose Utilization and c-fos Expression in the Rat

  2004cites this paper
• Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.

  2004cites this paper
• Role of the vestibular nuclei in endothelin-1-induced barrel rotation in rats.

  2002cites this paper
• Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness.

  2002cites this paper
• Cerebral glucose utilization in transgenic mice overexpressing heat shock protein 70 is altered by dizocilpine

  2002cites this paper
• The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.

  2002cites this paper
• The Competitive NMDA Receptor Antagonist CPPene Stimulates NREM Sleep and Eating in Rats

  2002cites this paper
• Brain Injury

  2001cites this paper
• Anesthetics and the Injured Brain

  2001cites this paper
• Iron in Central Nervous System Disorders

  2001cites this paper
• Neuroprotective effects of MK‐801 on l‐2‐chloropropionic acid‐induced neurotoxicity

  2001cites this paper
• MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets.

  2001cites this paper
• Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists.

  2000cites this paper
• Effects of Ketamine, MK-801, and Amphetamine on Regional Brain 2-Deoxyglucose Uptake in Freely Moving Mice

  2000influential citation
• Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.

  2000cites this paper
• Neuroprotection and functional alterations in mice over-expressing heat shock protein 70i.

  2000cites this paper
• Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.

  2000cites this paper
• LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.

  2000cites this paper
• Comparison of MK-801 and sleep deprivation effects on NREM, REM, and waking spectra in the rat.

  1999cites this paper
• First Observations of the Safety and Tolerability of a Competitive Antagonist to the Glutamate NMDA Receptor (CGS 19755) in Patients with Severe Head Injury

  1999cites this paper
• Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum

  1999cites this paper
• Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

  1999cites this paper
• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  1999cites this paper
• An integrated view of pathophysiological models of schizophrenia.

  1999cites this paper
• Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.

  1999cites this paper
• The effects of temperature and scopolamine on N-methyl-D-aspartate antagonist-induced neuronal necrosis in the rat.

  1999cites this paper
• Deleterious brain cell membrane effects after NMDA receptor antagonist administration to newborn piglets.

  1999cites this paper
• Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

  1998cites this paper
• Neurotoxiciy of NMDA Receptor Antagonists

  1998cites this paper
• Effects of NMDA receptor glycine recognition site antagonism on cerebral metabolic rate for glucose and cerebral blood flow in the conscious rat.

  1998cites this paper
• Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.

  1998cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

  1998cites this paper
• MK-801 neurotoxicity in the guinea pig cerebral cortex: susceptibility and regional differences compared with the rat.

  1997cites this paper
• Rapid Alteration of Tau in Oligodendrocytes After Focal Ischemic Injury in the Rat: Involvement of Free Radicals

  1997cites this paper
• A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure.

  1997cites this paper
• Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.

  1997cites this paper
• Coadministered pentobarbital anesthesia postpones but does not block the motor and sleep EEG responses to MK-801.

  1997cites this paper
• A new non-NMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure.

  1997cites this paper
• Structural neurotoxicologic investigation of the glycine antagonist 5-nitro-6,7-dichloroquinoxalinedione (ACEA-1021).

  1997cites this paper
• Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.

  1997cites this paper
• Effect of glutamate neurotoxicity on CaM kinase immunoreactivity in vivo

  1997cites this paper
• Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia.

  1996cites this paper
• NREM delta stimulation following MK-801 is a response of sleep systems.

  1996cites this paper
• Noncompetitive NMDA channel blockade during waking intensely stimulates NREM delta.

  1996cites this paper
• MK‐801 induces apoptotic neuronal death in the rat retrosplenial cortex: Prevention by cycloheximide and R(−)‐2‐Hexyl‐N‐ Methylpropargylamine

  1996cites this paper
• Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats.

  1996cites this paper
• Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.

  1996cites this paper
• Observations on delta homeostasis, the one-stimulus model of NREM-REM alternation and the neurobiologic implications of experimental dream studies.

  1995cites this paper
• Neuroprotection by the N‐Methyl‐d‐Aspartate Receptor Antagonist CGP 40116: In Vivo and In Vitro Studies

  1995cites this paper
• VISUALISATION OF CHANGES IN REGIONAL CEREBRAL BLOOD FLOW (rCBF) PRODUCED BY KETAMINE USING LONG TE GRADIENT-ECHO SEQUENCES: PRELIMINARY RESULTS

  1995cites this paper
• Hypofrontality does not occur with 6-hydroxydopamine lesions of the medial prefrontal cortex in rat brain.

  1995cites this paper
• Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.

  1995cites this paper
• AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex.

  1995cites this paper
• The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

  1995cites this paper
• NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.

  1994cites this paper
• AMPA receptor antagonists and local cerebral glucose utilization in the rat.

  1994cites this paper
• Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils.

  1994cites this paper
• Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.

  1994cites this paper
• Effect of neuroprotective N-methyl-D-aspartate antagonists on increased intracranial pressure: studies in the rat acute subdural hematoma model.

  1994cites this paper
• Thrombolytic therapy in experimental embolic stroke.

  1994cites this paper
• Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain.

  1994cites this paper
• Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.

  1994cites this paper
• Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists.

  1994cites this paper
• Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels.

  1994cites this paper
• Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat in the rat brain.

  1994cites this paper
• Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by spectral EEG and infarct volume.

  1994cites this paper
• Consequences of intrastriatally administrated FeCl3 and 6-OHDA without and after transient cerebral oligemia on behaviour and navigation

  1993cites this paper
• Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801.

  1993cites this paper
• Neuroprotective Doses of N‐Methyl‐D‐Aspartate Receptor Antagonists Profoundly Reduce the Minimum Alveolar Anesthetic Concentration (MAC) for Isoflurane in Rats

  1993cites this paper
• Noncompetitive and competitive NMDA antagonists exert anticonvulsant effects by actions on different sites within the neuronal network for audiogenic seizures.

  1993cites this paper
• Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism

  1993cites this paper
• Neuroprotection by Excitatory Amino Acid Antagonist Augments the Benefit of Thrombolysis in Embolic Stroke in Rats

  1993cites this paper
• Dissimilar patterns of degeneration in brain following four different addictive stimulants

  1993cites this paper
• Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists.

  1993cites this paper
• The monosialoganglioside GM1 dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.

  1993cites this paper
• Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRI

  1993cites this paper
• Diffusion and Perfusion Magnetic Resonance Imaging Studies to Evaluate a Noncompetitive N‐Methyl‐D‐aspartate Antagonist and Reperfusion in Experimental Stroke in Rats

  1993cites this paper
• Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.

  1993cites this paper
• Nuclear Imaging in Drug Development — Introduction

  1993cites this paper
• The Effects of NMDA Antagonists on Intracranial Pressure in a Model of Acute Subdural Haematoma in the Rat

  1993cites this paper
• Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)5 an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

  1993cites this paper
• Ketamine Administration During Waking Increases Delta EEG Intensity in Rat Sleep

  1993cites this paper
• Effect of the Non‐NMDA Receptor Antagonist, 2,3‐Dihydro‐6‐Nitro‐7‐Sulfamoylbenzo(f)quinoxaline, on Local Cerebral Glucose Uptake in the Limbic Forebrain

  1993cites this paper
• Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids.

  1992cites this paper